A completely valid question. Sales of Mabthera have continued to grow, but it is not possible to find any break-out of sub sales.
One can, and will, only conjecture on the significance of this based on ones point of view. Observer bias. Mabthera is a big seller. I'd like to know why sun isn't being more visibly touted.
Janssen's new myeloma drug received unusually rapid FDA approval. Bodes well for the HALO partner, perhaps. That's only if the FDA doesn't totally freak about the antibodies. Oh, goodness, the antibodies!